...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >IgG-Switched cll has a distinct immunogenetic signature from the common md variant: Ontogenetic implications
【24h】

IgG-Switched cll has a distinct immunogenetic signature from the common md variant: Ontogenetic implications

机译:IgG转换的cll具有与常见md变体不同的免疫遗传学特征:遗传学意义

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Immunoglobulin G-switched chronic lymphocytic leukemia (G-CLL) is a rare variant of CLL, whose origin and ontogenetic relationship to the common IgM/IgD (MD-CLL) variant remains undefined. Here, we sought for clues about the ontogeny of G-CLL versus MD-CLL by profiling the relevant IG gene repertoires. Experimental Design: Using purpose-built bioinformatics methods, we performed detailed immunogenetic profiling of a multinational CLL cohort comprising 1,256 cases, of which 1,087 and 169 expressed IG mu/delta and gamma heavy chains, respectively. Results: G-CLL has a highly skewed IG gene repertoire that is distinct from MD-CLL, especially in terms of (i) overuse of the IGHV4-34 and IGHV4-39 genes and (ii) differential somatic hypermutation (SHM) load. Repertoire differences were also found when comparing subgroups with similarSHMstatus and were mainly attributed to the exclusive representation in G-CLL of two major subsets with quasi-identical (stereotyped) B-cell receptors. These subsets, namely #4 (IGHV4-34/IGKV2-30) and #8 (IGHV4-39/IGKV1(D)-39), were found to display sharply contrasting SHM and clinical behavior. Conclusions: G-CLL exhibits an overall distinct immunogenetic signature from MD-CLL, prompting speculations about distinct ontogenetic derivation and/or immune triggering. The reasons underlying the differential regulation of SHM among G-CLL cases remain to be elucidated. Clin Cancer Res; 20(2); 323-30.
机译:目的:免疫球蛋白G转换慢性淋巴细胞性白血病(G-CLL)是CLL的罕见变体,其起源和与常见IgM / IgD(MD-CLL)变体的遗传关系仍然不确定。在这里,我们通过对相关的IG基因谱进行分析来寻找有关G-CLL与MD-CLL的个体发育的线索。实验设计:使用专门建立的生物信息学方法,我们对包括1,256例病例的跨国CLL队列进行了详细的免疫遗传学分析,其中1,087和169例分别表达了IG mu / delta和γ重链。结果:G-CLL具有与MD-CLL截然不同的高度IG基因库,特别是在(i)过度使用IGHV4-34和IGHV4-39基因以及(ii)差异性体细胞超突变(SHM)负荷方面。比较具有相似SHMstatus的亚组时,还发现库差异,这主要归因于具有准相同(定型)B细胞受体的两个主要亚群在G-CLL中的排他性表示。发现这些子集,即#4(IGHV4-34 / IGKV2-30)和#8(IGHV4-39 / IGKV1(D)-39),表现出与SHM和临床行为形成鲜明对比。结论:G-CLL表现出与MD-CLL完全不同的免疫遗传学特征,促使人们对不同的个体遗传衍生和/或免疫触发进行了推测。 G-CLL病例中SHM差异调节的根本原因尚待阐明。临床癌症研究; 20(2); 323-30。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号